The AIDS Clinical Conference series is typically held on the 3rd Tuesday of every month from 8am–9am Pacific Time at University of Washington’s Harborview Medical Center.
This conference is one of the longest running clinical HIV conferences in the United States. Over the last 30+ years, literally hundreds of speakers from around the country and the world have delivered lectures on a wide variety of HIV topics from prevention and vaccine research to antiretroviral therapy, drug resistance and the adverse effects of HIV treatment.
The grand rounds like conference is popular among regional and national HIV providers, University of Washington (UW) faculty, housestaff and public health staff. The Harborview Medical Center’s Madison Clinic (the largest provider of HIV care in the Northwest), the University of Washington Center for AIDS Research (CFAR), Treatment Research and Expert Education (TREE), and the MWAETC sponsor the conference.
Nurses may earn 1.0 CNE contact hour if they complete the evaluation after the live event or register and attend the live webinar and complete the evaluation by Friday noon after the conference.
Topics and speakers are subject to change. The conference is from 8am-9am.
Dates |
Topics |
Speakers |
---|---|---|
1/16/18 |
Inflammation & HIV | Peter W. Hunt, MD |
2/20/18 |
Tuberculosis & HIV | Christopher Spitters, MD, MPH |
3/20/18 |
CROI Update | UW faculty |
4/17/18 |
Cancer & HIV | Manoj Menon, MD, MPH |
5/15/18 |
PrEP | Jared Baeten, MD, PhD |
6/19/18 |
STIs and HIV | Julie Dombrowski, MD, MPH |
7/17/18 |
HIV Prevention Update | A Principles Course Speaker |
9/18/18 |
Women and HIV | Kathy Brown, MD |
10/16/18 |
HIV Drug Resistance | David Spach, MD |
11/13/18 |
ARV Update | Brian Wood, MD |
Registration is not required to attend the live event at the Research and Training Building Auditorium, 300 9th Avenue, Seattle 98104 but pre-registration is required for the webinar.
If you would like to join the ACC email list (which means you receive two notices with webinar registration links for each ACC), please click here. We do not share the mailing list.
Below you will find links to view recordings of some past ACCs.
1/16: Peter W. Hunt, MD
Immune Activation in Treated HIV: Does It Still Matter?
2/20: Christopher Spitters, MD, MPH
Tuberculosis in HIV Patients
3/20: Julie Dombrowski, MD, Ann Collier, MD, Adrienne Shapiro, MD, PhD,
Robert Harrington, MD
2018 CROI Update
Correction: At 26 minutes 19 seconds, "cabotegravir" should be "dolutegravir."
4/17: Manoj P. Menon, MD, MPH
Treating Cancer Patients Who Are HIV Positive: A Clinical Update
11/14: Brian R. Wood, MD
The Future of Antiretroviral Therapy: New Agents and Strategies
10/17: H. Nina Kim, MD, MSc
Chronic Hepatitis B and HIV: Remaining Challenges in Coinfection
9/19: Kevin Ard, MD, MPH
HIV and STIs in Transgender Populations
7/18: Thomas Quinn, MD, MSc
Biomedical Prevention for HIV Control: From Research to Reality
6/20: Scott Letendre, MD
The Impact of HIV and Aging on the Brain
5/16: Christine Yuodelis-Flores, MD
Triple Diagnoses: Mental Illness, Addiction and HIV
4/18: Judy Levison, MD, MPH
New Frontiers in Safe Sex: It is Not Just About Condoms
3/21: Robert D. Harrington, MD, Brian Wood, MD, Ann Collier, MD, and Julie Dombrowski, MD
2017 CROI Update
2/21: Roxanne Kerani, PhD, MPH
Stigma and HIV Care in America's African-born Community
1/17: Wayne C. McCormick, MD, MPH and Heidi Crane, MD, MPH
Aging & HIV
11/15: Madeline B. Deutsch, MD, MPH
Transgender Health and HIV
10/18: Joe Merrill, MD, MPH
Update on Opioid Use Disorders
9/20: Christina Wyatt, MD
The Kidney in HIV Infection, Treatment & Prevention
6/21: Robert Rakita, MD
Solid Organ Transplant and HIV
5/17: David Wyles, MD
HCV in 2016: Treatment of the Co-infected Patient and Management of Viral Resistance
11/17: Steven Shoptaw, PhD
Methamphetamine Use, Mental Health and HIV
10/20: Roy Colven, MD
HIV and the Skin: Selected Topics
9/15: Priscilla Hsue, MD
HIV and Cardiovascular Disease
7/23: Myron S. Cohen, MD
Global Prevention of HIV: Where do we go from here?
5/19: Robert Shafer, MD
Management of Patients with Transmitted and Aquired Drug Resistance
4/21: Sophie Woolston, MD, Matthew Golden, MD, MPH, Sheila Lukehart, PhD
Ocular Syphilis: Bench to Bedside
2/18: Joanne Stekler, MD
Experiences with PEP and PrEP in Seattle